JW Pharmaceutical(1P) Pref Shs (001065) Stock Price & News

001065:KRX

JW Pharmaceutical(1P) Pref Shs

₩21,300.00

0.00%

(0.00) 1D

Oct 16, 3:30:30 PM GMT+9 · KRW

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 001065...

Open

₩21,300

High

₩21,300

Low

₩21,100

Mkt. cap

606.87B

Avg. vol.

122.00

Volume

34.00

Dividend

3.05%

Quarterly dividend

₩162

Ex-dividend date

Dec 27, 2023

P/E ratio

5.08

52-wk high

₩30,300

52-wk low

₩19,710

EPS

₩4,193

Shares outstanding

341.95K

No. of employees

Open

₩21,300

High

₩21,300

Low

₩21,100

Mkt. cap

606.87B

Avg. vol.

122.00

Volume

34.00

Dividend

3.05%

Quarterly dividend

₩162

Ex-dividend date

Dec 27, 2023

P/E ratio

5.08

52-wk high

₩30,300

52-wk low

₩19,710

EPS

₩4,193

Shares outstanding

341.95K

No. of employees

Related stocks

001067

JW Pharmaceutical(2Pb) Pref Shs

₩49,850.00

-0.10%

000105

Yuhan Corp Preference Shares

₩66,800.00

+4.38%

000640

Dong-A Socio Holdings Co Ltd

News stories

From web sources and news partners

Bloomberg.com

23 minutes ago

S&P 500 Steady as Warsh Boosts Expectations of Rate Hold

Quartz

26 minutes ago

Dow rises while Nasdaq slips as chip stocks pull Wall Street toward a weekly loss

The Motley Fool

7 minutes ago

S&P 500 Stock Casey's Dropped 30% in Its Biggest Pullback Since the Great Recession -- Here's Why I'm Buying More

Yahoo Finance

1 hour ago

S&P 500 Bull Market Has Reasons For Optimism, Says Baird — But Higher Rates Could Favor Quality Stocks

About JW Pharmaceutical(1P) Pref Shs

CEOLee, Kyung Ha

Employees1.05K

Founded1945

Headquarters-

SectorPharmaceutical industry

Websitejw-pharma.co.kr

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	200.02B	198.94B	199.88B	222.02B
Cost of goods sold	105.39B	109.09B	101.43B	116.73B
Cost of revenue	105.39B	109.09B	101.43B	116.73B
Research and development expenses	7.33B	15.27B	9.38B	11.86B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	55.58B	60.42B	55.91B	59.90B
Operating expense	62.60B	80.98B	64.88B	71.95B
Total operating expenses	167.99B	190.07B	166.31B	188.68B
Operating income	32.03B	8.87B	33.58B	33.34B
Other non operating income	-4.64B	8.03B	1.21B	835.27M
EBT including unusual items	27.85B	17.49B	35.20B	34.76B
EBT excluding unusual items	27.85B	15.96B	35.20B	34.76B
Income tax expense	-2.74B	2.18B	7.72B	6.86B
Effective tax rate	-9.83%	12.44%	21.93%	19.75%
Other operating expenses	-	-	-	-
Net income	30.59B	15.32B	27.48B	27.89B
Net profit margin	15.29%	7.70%	13.75%	12.56%
Earnings per share	1.27K	-	-	-
Interest and investment income	-	3.34B	-	-
Interest expense	-	-4.42B	-	-
Net interest expenses	-	-1.09B	-	-
Depreciation and amortization charges	-	-	-	-
EBITDA	36.72B	13.65B	38.56B	38.37B
Gain or loss from assets sale	5.12M	3.00K	-10.00M	3.00K

Ask anything